American Board of Orthodontics (ABO) 2025 – 400 Free Practice Questions to Pass the Exam

Dental implants can be considered safe to place in patients using oral bisphosphonates, provided that proper precautions and assessments are taken. Bisphosphonates are commonly used to treat conditions such as osteoporosis and Paget's disease, and while they have been associated with potential complications like osteonecrosis of the jaw (ONJ), the risk is often linked more with intravenous formulations than with oral bisphosphonates.

In practice, the decision to place dental implants involves evaluating the patient's overall health, the specific bisphosphonate being used, the duration of treatment, and the dental condition of the patient. Many studies have shown that the risk of complications is significantly lower when the bisphosphonates are taken orally, particularly at standard doses, compared to higher doses administered intravenously. Moreover, patients on oral bisphosphonates generally do not have the same level of risk for ONJ As those on intravenous therapy.

Therefore, with appropriate consultation, risk assessment, and monitoring, dental implants can be safely placed in patients using oral bisphosphonates, affirming the view that it is indeed a feasible option in these cases. The overall conclusion is that it’s a well-tolerated procedure for candidates under such medication when measured